Acute liver failure associated with Garcinia cambogia use

Annals of Hepatology

Volumn 15, Issue 1, 2016, Pages 123-126

  Corey, Rebecca ^a   Werner, K Tuesday ^a   Singer, Andrew ^a   Moss, Adyr ^a   Smith, Maxwell ^a   Noelting, Jessica ^a   Rakela, Jorge ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hepatotoxicity; Herbal supplements; Transplantation

Indexed keywords

BILIRUBIN; HERBACEOUS AGENT; ANTIOBESITY AGENT; PLANT MEDICINAL PRODUCT;

ACUTE HEPATITIS; ACUTE LIVER FAILURE; ADULT; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GARCINIA CAMBOGIA; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PARENCHYMA; LIVER TRANSPLANTATION; LIVER WEIGHT; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; POSTOPERATIVE PERIOD; SCORING SYSTEM; SYMPTOM; TOXIC HEPATITIS; VIRUS HEPATITIS; WEIGHT REDUCTION; ADVERSE EFFECTS; BIOPSY; CHEMICALLY INDUCED; LIVER FAILURE, ACUTE; LIVER FUNCTION TEST; MEDICINAL PLANT; PHYTOTHERAPY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANTI-OBESITY AGENTS; BIOPSY; FEMALE; GARCINIA CAMBOGIA; HUMANS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84949256782     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.5604/16652681.1184287     Document Type: Article

References (15)

1. Corey RL, Rakela J. Complementary and alternative medicine: risks and special considerations in pretransplant and posttransplant patients. Nutr Clin Pract 2014; 29: 322-31.
2. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-6.
3. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.
4. Blanck HM, Serdula MK, Gillespie C, Galuska DA, Sharpe PA, Conway JM, Khan LK, et al. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007; 107: 441-7.
5. Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY, Nashan B, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transp 2006; 12: 1892-5.
6. Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M. Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis 2007; 39: 953-5.
7. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005; 142: 477-8.
8. CDC Health Alert Network. Acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building. Available from: http://emergency.cdc.gov/han/han00356.asp [Accessed March 4, 2015]
9. FDA Investigation Summary: Acute Hepatitis Illnesses Linked to Certain OxyElite Pro Products. Available from: http://www.fda.gov/food/recallsoutbreaksemergencies/outbreaks/ucm370849.htm [Accessed March 4, 2015].
10. Kim YJ, Choi MS, Park YB, Kim SR, Lee MK, Jung UJ. Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. World J Gastroenterol 2013; 19: 4689-701.
11. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998; 280: 1596-1600.
12. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004; 79: 529-36.
13. Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. The Use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: A systematic review and meta-analysis of randomised clinical trials. J Obes 2011; 2011: 509038.
14. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-35.
15. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141: 1665-1672, e1661-e1669.